Creative Medical Technology Holdings 宣布“奥拉斯特洛细胞”获得世界卫生组织批准,成为主要异体细胞疗法Celz-201的国际非专利名称。
Creative Medical Technology Holdings 宣布“奥拉斯特洛细胞”获得世界卫生组织批准,成为主要异体细胞疗法Celz-201的国际非专利名称。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.